Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Arrow Pharma Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (162)
Cancellation or suspension (56)
Prescription medicine registration (4)
Listed medicine compliance report (1)
Section 14, TGO91 consent (1)

Date

2024 (8)
2023 (32)
2022 (84)
2021 (40)
2020 (11)
2019 (23)
2018 (24)
2017 (2)

Search

Sponsor content

224 result(s) found, displaying 61 to 70

MIRTAZAPINE ARW mirtazapine 15 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Arrow Pharma Pty Ltd
ACPIO 30 pioglitazone (as hydrochloride) 30 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Arrow Pharma Pty Ltd
ACPIO 15 pioglitazone (as hydrochloride) 15 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Arrow Pharma Pty Ltd
VENLAFAXINE ARW XR venlafaxine (as hydrochloride) 150 mg modified release capsule blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Arrow Pharma Pty Ltd
VENLAFAXINE ARW XR venlafaxine (as hydrochloride) 75 mg modified release capsule blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Arrow Pharma Pty Ltd
VENLAFAXINE ARW XR venlafaxine (as hydrochloride) 37.5 mg modified release capsule blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Arrow Pharma Pty Ltd
SERONIA 100 quetiapine (as fumarate) 100 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Arrow Pharma Pty Ltd
SERONIA 300 quetiapine (as fumarate) 300 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Arrow Pharma Pty Ltd
SERONIA 200 quetiapine (as fumarate) 200 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Arrow Pharma Pty Ltd
SERONIA 25 quetiapine (as fumarate) 25 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Arrow Pharma Pty Ltd

Pages

First page
Previous page
…
Page 3
Page 4
Page 5
Page 6
Current page 7
Page 8
Page 9
Page 10
Page 11
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.